세계의 분자 접착제 분해제 시장 : 유형별, 전달 방법별, 최종사용자별, 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 점유율 및 예측(2025-2032년)

The Molecular Glue Degradation Agent Market size was valued at US$ 402 Million in 2024, expanding at a CAGR 8.6% from 2025 to 2032.

The Molecular Glue Degradation Agent Market is an emerging segment of targeted protein degradation (TPD) therapies that use molecular glues-small molecules that induce proximity between a target protein and an E3 ubiquitin ligase, resulting in selective protein degradation. The Molecular Glue Degradation Agent Market is expanding rapidly, driven by the growing demand for therapies capable of degrading previously "undruggable" proteins, particularly in oncology and rare diseases. A major market trend is the rapid adoption of AI-enabled platforms and structure-based design tools, which accelerate the discovery of novel molecular glue degraders. However, a significant challenge to faster commercial progress is a lack of regulatory clarity, as well as the difficulty of predicting target selectivity and off-target effects in early development. Despite this, there is a significant opportunity to expand molecular glue applications beyond cancer to include neurodegenerative, inflammatory, and metabolic disorders, where targeted protein degradation could lead to first-in-class therapeutic breakthroughs.

Molecular Glue Degradation Agent Market- Market Dynamics

Growing Demand for Sustainable Manufacturing Propels Market Growth

The rising demand for sustainable manufacturing is a significant growth driver in the Molecular Glue Degradation Agent market, as pharmaceutical companies prioritize environmentally responsible drug development. Molecular glues contribute to sustainability goals by allowing for targeted protein degradation using small, efficient molecules that require fewer raw materials, have simpler synthesis steps, and produce less chemical waste than traditional approaches. As global pressure grows to reduce pharmaceutical production's environmental footprint, manufacturers are accelerating the use of greener chemistry and energy-efficient development platforms. Strategic industry collaborations help to reinforce this trend. For instance, in May 2024, Takeda Pharmaceuticals signed a licensing agreement with Degron Therapeutics worth up to USD 1.2 billion to develop scalable molecular glue degraders, reflecting the market's shift toward more sustainable and resource-efficient therapeutic solutions. This sustainable trend is expected to drive market growth in the coming years.

Molecular Glue Degradation Agent Market- Segmentation Analysis:

The worldwide market is segmented on the basis of Type, Delivery Method, End User, Application, and Region.

Based End-User segmentation, the pharmaceutical company's segment is one of the most important categories in the Global Molecular Glue Degradation Agent Market because they drive clinical development and commercialization of new targeted therapies. Molecular glues, such as PROTACs and LYTACs, are increasingly being studied for their ability to selectively degrade disease-causing proteins, making them ideal for novel drug pipelines. For instance, In December 2024, Monte Rosa Therapeutics reported that the dose-escalation phase of its Phase I/II trial of MRT-2359 demonstrated a favorable safety profile and effective GSPT1 degradation using a 21-day-on, 7-day-off dosing regimen in heavily pretreated solid tumor patients. Further clinical data, including biomarker and activity insights, are expected in Q1 2025, highlighting ongoing progress in targeted protein degradation in the pharmaceutical and biotechnology industries.

Based on Type segment, The Proteolytic Targeting Chimeras (PROTAC-like) segment is an important component in the Molecular Glue Degradation Agent Market because it allows for the selective recruitment of E3 ubiquitin ligases to degrade pathogenic proteins, providing a powerful solution for previously "undruggable" targets. Its significance is underscored by robust industry activity, such as Monte Rosa Therapeutics' advances in molecular glue degraders. In April 2025, the company presented preclinical data demonstrating that its CDK2-directed degrader MRT-51443 improved tumor regression in HR-positive/HER2-negative breast cancer models when combined with existing therapies. Monte Rosa's 2025 pipeline update also highlighted upcoming IND submissions, including MRT-8102 for NEK7 degradation and the continued development of solid-tumor candidate MRT-2359. Monte Rosa's major partnership with Novartis in late 2024, which included a $150 million upfront payment and potential milestones exceeding $2 billion for its VAV1-targeted glue degraders, underscores the segment's commercial relevance. These developments collectively highlight the PROTAC-like segment as a high-value growth engine in the molecular glue degradation ecosystem.

Molecular Glue Degradation Agent Market- Geographical Insights

North America's market is distinguished by significant investments in biotechnology and pharmaceutical research, which are supported by a robust infrastructure and a concentration of leading research institutions and companies. Meanwhile, the Middle East and Africa offer a diverse market landscape, with growth opportunities driven by improved healthcare systems and investments in life sciences. Finally, Latin America is gradually expanding, with increased interest in biopharmaceutical development and collaborations creating an enabling environment for biotechnology advancement. The geographical segmentation highlights varying degrees of maturation, investment, and regulatory environments, which have a significant impact on global market dynamics for molecular glue degradation agents.

United States Molecular Glue Degradation Agent Market- Country Insights

The United States is the most important country in the North American Molecular Glue Degradation Agent Market due to its robust biotech ecosystem, advanced research infrastructure, and rapid adoption of next-generation targeted protein degradation technologies. The country is home to leading pharmaceutical innovators, top academic research institutions, and a dense network of clinical trial sites, allowing for faster translation of molecular glue concepts into clinical-stage therapeutics. Furthermore, the United States benefits from supportive FDA pathways for breakthrough therapies and robust venture capital investment, both of which accelerate market expansion. This leadership is evident in developments such as AbbVie's January 2025 collaboration with Neomorph, in which the biotech received up to USD 1.64 billion to advance molecular glue degraders in oncology and immunology-demonstrating how U.S.-led partnerships and funding commitments are shaping the global trajectory of molecular glue technologies.

Molecular Glue Degradation Agent Market- Competitive Landscape:

The Molecular Glue Degradation Agent market is highly competitive, driven by innovation in targeted protein degradation and strategic collaborations. Arvinas, a pioneer in PROTAC and molecular glue technologies, has advanced multiple candidates to clinical trials in oncology and other areas. Kymera Therapeutics is well-known for its proprietary E3 ligase-targeting platforms and lucrative collaborations with Gilead and other pharmaceutical companies to develop novel molecular glues. C4 Therapeutics also uses its integrated BiDAC and MonoDAC platforms to accelerate the discovery and clinical development of molecular glue degraders. These companies, along with other innovators such as AbbVie and Genentech, are shaping the competitive landscape through technological leadership, pipeline advancement, and strategic alliances, putting them at the forefront of this rapidly changing market.

Recent Developments:

In March 2025, Magnet Biomedicine has formed a collaboration and licensing agreement with Eli Lilly to identify, develop, and market oncology-focused molecular glue therapies.

In January 2025, AbbVie and Neomorph, Inc. announced a collaboration and licensing agreement to develop novel molecular glue degraders for oncology and immunology.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MOLECULAR GLUE DEGRADATION AGENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• Arvinas
• Jiangsu Chia Tai-Tianqing
• Nanjing Shunxin
• C4 Therapeutics
• AbbVie
• Venquis Therapeutics
• Monte Rosa Therapeutics
• Qilu Pharmaceutical
• Kymera Therapeutics
• Genentech (Roche)
• Takeda Pharmaceuticals
• Eli Lilly and Company
• Bristol-Myers Squibb
• Pfizer
• Gilead Sciences
• Hansoh
• Beijing SL
• Yangtze River

GLOBAL MOLECULAR GLUE DEGRADATION AGENT MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

• Lysosome Targeting Chimeras
• Proteolytic Targeting Chimeras
• Others

GLOBAL MOLECULAR GLUE DEGRADATION AGENT MARKET, BY DELIVERY METHOD- MARKET ANALYSIS, 2019 - 2032

• Oral
• Injectable

GLOBAL MOLECULAR GLUE DEGRADATION AGENT MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

• Pharmaceutical Companies
• Academic and Research Institutions
• Biotechnology Firms

GLOBAL MOLECULAR GLUE DEGRADATION AGENT MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

• Consumer Electronics
• Automotive
• Telecom & Datacom
• Energy & Power
• Industrial
• Others

GLOBAL MOLECULAR GLUE DEGRADATION AGENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Sweden
• Russia
• Poland
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Thailand
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Molecular Glue Degradation Agent Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Molecular Glue Degradation Agent Market Snippet by Type
  • 2.1.2. Molecular Glue Degradation Agent Market Snippet by Delivery Method
  • 2.1.3. Molecular Glue Degradation Agent Market Snippet by End User
  • 2.1.4. Molecular Glue Degradation Agent Market Snippet by Application
  • 2.1.5. Molecular Glue Degradation Agent Market Snippet by Country
  • 2.1.6. Molecular Glue Degradation Agent Market Snippet by Region
• 2.2. Competitive Insights

3. Molecular Glue Degradation Agent Key Market Trends

• 3.1. Molecular Glue Degradation Agent Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Molecular Glue Degradation Agent Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Molecular Glue Degradation Agent Market Opportunities
• 3.4. Molecular Glue Degradation Agent Market Future Trends

4. Molecular Glue Degradation Agent Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Molecular Glue Degradation Agent Market: Impact of Escalating Geopolitical Tensions

• 5.1. Impact of COVID-19 Pandemic
• 5.2. Impact of Russia-Ukraine War
• 5.3. Impact of Middle East Conflicts

6. Molecular Glue Degradation Agent Market Landscape

• 6.1. Molecular Glue Degradation Agent Market Share Analysis, 2024
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Molecular Glue Degradation Agent Market - By Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
  • 7.1.2. Lysosome Targeting Chimeras
  • 7.1.3. Proteolytic Targeting Chimeras
  • 7.1.4. Others

8. Molecular Glue Degradation Agent Market - By Delivery Method

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Delivery Method, 2024 & 2032 (%)
  • 8.1.2. Oral
  • 8.1.3. Injectable

9. Molecular Glue Degradation Agent Market - By End User

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
  • 9.1.2. Pharmaceutical Companies
  • 9.1.3. Academic and Research Institutions
  • 9.1.4. Biotechnology Firms

10. Molecular Glue Degradation Agent Market - By Application

• 10.1. Overview
  • 10.1.1. Segment Share Analysis, By Delivery Method, 2024 & 2032 (%)
  • 10.1.2. Consumer Electronics
  • 10.1.3. Automotive
  • 10.1.4. Telecom & Datacom
  • 10.1.5. Energy & Power
  • 10.1.6. Industrial
  • 10.1.7. Others

11. Molecular Glue Degradation Agent Market- By Geography

• 11.1. Introduction
  • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
• 11.2. North America
  • 11.2.1. Overview
  • 11.2.2. Molecular Glue Degradation Agent Key Manufacturers in North America
  • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 11.2.5. North America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  • 11.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.2.8. U.S.
    • 11.2.8.1. Overview
    • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.8.4. U.S. Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.2.8.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.2.9. Canada
    • 11.2.9.1. Overview
    • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.9.4. Canada Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.2.9.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
• 11.3. Europe
  • 11.3.1. Overview
  • 11.3.2. Molecular Glue Degradation Agent Key Manufacturers in Europe
  • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 11.3.5. Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  • 11.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.3.8. Germany
    • 11.3.8.1. Overview
    • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.8.4. Germany Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.3.8.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.3.9. UK
    • 11.3.9.1. Overview
    • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.9.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.9.4. UK Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.3.9.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.3.10. France
    • 11.3.10.1. Overview
    • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.10.4. France Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.3.11. Italy
    • 11.3.11.1. Overview
    • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.11.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.11.4. Italy Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.3.11.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.3.12. Spain
    • 11.3.12.1. Overview
    • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.12.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.12.4. Spain Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.3.12.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.3.13. The Netherlands
    • 11.3.13.1. Overview
    • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.13.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.13.4. The Netherlands Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.3.13.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.3.14. Sweden
    • 11.3.14.1. Overview
    • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.14.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.14.4. Sweden Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.3.15. Russia
    • 11.3.15.1. Overview
    • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.15.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.15.4. Russia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.3.15.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.3.16. Poland
    • 11.3.16.1. Overview
    • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.16.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.16.4. Poland Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.3.16.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.3.17. Rest of Europe
    • 11.3.17.1. Overview
    • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.3.17.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.17.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
• 11.4. Asia Pacific (APAC)
  • 11.4.1. Overview
  • 11.4.2. Molecular Glue Degradation Agent Key Manufacturers in Asia Pacific
  • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 11.4.5. APAC Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  • 11.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.4.8. China
    • 11.4.8.1. Overview
    • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.8.4. China Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.4.9. India
    • 11.4.9.1. Overview
    • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.9.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.9.4. India Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.4.9.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.4.10. Japan
    • 11.4.10.1. Overview
    • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.10.4. Japan Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.4.10.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.4.11. South Korea
    • 11.4.11.1. Overview
    • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.11.4. South Korea Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.4.11.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.4.12. Australia
    • 11.4.12.1. Overview
    • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.12.4. Australia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.4.12.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.4.13. Indonesia
    • 11.4.13.1. Overview
    • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.13.4. Indonesia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.4.14. Thailand
    • 11.4.14.1. Overview
    • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.14.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.14.4. Thailand Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.4.14.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.4.15. Philippines
    • 11.4.15.1. Overview
    • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.15.4. Philippines Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.4.15.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.4.16. Rest of APAC
    • 11.4.16.1. Overview
    • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.16.4. Rest of APAC Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.4.16.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
• 11.5. Latin America (LATAM)
  • 11.5.1. Overview
  • 11.5.2. Molecular Glue Degradation Agent Key Manufacturers in Latin America
  • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 11.5.5. LATAM Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  • 11.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.5.8. Brazil
    • 11.5.8.1. Overview
    • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.8.4. Brazil Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.5.8.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.5.9. Mexico
    • 11.5.9.1. Overview
    • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.9.4. Mexico Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.5.9.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.5.10. Argentina
    • 11.5.10.1. Overview
    • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.10.4. Argentina Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.5.10.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.5.11. Colombia
    • 11.5.11.1. Overview
    • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.11.4. Colombia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.5.11.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.5.12. Rest of LATAM
    • 11.5.12.1. Overview
    • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.5.12.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
• 11.6. Middle East and Africa (MEA)
  • 11.6.1. Overview
  • 11.6.2. Molecular Glue Degradation Agent Key Manufacturers in Middle East and Africa
  • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 11.6.5. MEA Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  • 11.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6.7. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.6.8. Saudi Arabia
    • 11.6.8.1. Overview
    • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.6.8.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.6.9. United Arab Emirates
    • 11.6.9.1. Overview
    • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.6.9.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.6.10. Israel
    • 11.6.10.1. Overview
    • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.10.4. Israel Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.6.10.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.6.11. Turkey
    • 11.6.11.1. Overview
    • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.11.4. Turkey Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.6.11.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.6.12. Algeria
    • 11.6.12.1. Overview
    • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.12.4. Algeria Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.6.12.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.6.13. Egypt
    • 11.6.13.1. Overview
    • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.13.4. Egypt Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.6.13.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.6.14. Rest of MEA
    • 11.6.14.1. Overview
    • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.14.4. Rest of MEA Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.6.14.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Molecular Glue Degradation Agent Industry

• 12.1. Competitive Benchmarking
  • 12.1.1. Competitive Dashboard
  • 12.1.2. Competitive Positioning
• 12.2. Company Profiles
  • 12.2.1. Arvinas
  • 12.2.2. Jiangsu Chia Tai-Tianqing
  • 12.2.3. Nanjing Shunxin
  • 12.2.4. C4 Therapeutics
  • 12.2.5. AbbVie
  • 12.2.6. Venquis Therapeutics
  • 12.2.7. Monte Rosa Therapeutics
  • 12.2.8. Qilu Pharmaceutical
  • 12.2.9. Kymera Therapeutics
  • 12.2.10. Genentech (Roche)
  • 12.2.11. Takeda Pharmaceuticals
  • 12.2.12. Eli Lilly and Company
  • 12.2.13. Bristol-Myers Squibb
  • 12.2.14. Pfizer
  • 12.2.15. Gilead Sciences
  • 12.2.16. Hansoh
  • 12.2.17. Beijing SL
  • 12.2.18. Yangtze River

13. 360 Degree AnalystView

14. Appendix

• 14.1. Research Methodology
• 14.2. References
• 14.3. Abbreviations
• 14.4. Disclaimer
• 14.5. Contact Us